Association of State Marijuana Legalization Policies for Medical and Recreational Use With Vaping-Associated Lung Disease

JAMA Network Open

Volumn 3, Issue 4, 2020, Pages E202187-

  Wing, Coady ^a   Bradford, Ashley C ^a   Carroll, Aaron E ^b   Hollingsworth, Alex ^a  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL CANNABIS;

ADVERSE EVENT; CANNABIS SMOKING; CROSS-SECTIONAL STUDY; HUMAN; LEGISLATION AND JURISPRUDENCE; LUNG DISEASE; UNITED STATES; VAPING;

CROSS-SECTIONAL STUDIES; HUMANS; LUNG DISEASES; MARIJUANA SMOKING; MEDICAL MARIJUANA; UNITED STATES; VAPING;

EID: 85083071516     PISSN: None     EISSN: 25743805     Source Type: Journal    
DOI: 10.1001/jamanetworkopen.2020.2187     Document Type: Article

References (4)

1. Layden JE, Ghinai I, Pray I, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin—preliminary report. N Engl J Med. 2019. doi:10.1056/NEJMoa1911614
2. Perrine CG, Pickens CM, Boehmer TK, et al; Lung Injury Response Epidemiology/Surveillance Group. Characteristics of a multistate outbreak of lung injury associated with e-cigarette use, or vaping—United States, 2019. MMWR Morb Mortal Wkly Rep. 2019;68(39):860-864. doi:10.15585/mmwr.mm6839e1
3. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data. US Department of Health and Human Services, Centers for Disease Control and Prevention; 2017.
4. Surveillance, Epidemiology, and End Results Program, National Cancer Institute. US population data—1969-2018. Published December 2018. Accessed October 15, 2019. https://www.seer.cancer.gov/popdata